Morgans healthcare update
Scott Power
Morgans
A number of companies reported quarterly results late last week, we examine how some of the emerging medical device stories are playing out. Watch below to see what we think about Nanosonics (ASX:NAN), Impedimed(ASX:IPD), Admedus(ASX:AHZ) and Neuren Pharmaceuticals (ASX:NEU). To access more insights click the (VIEW LINK)
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media.
I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these sectors, which help with identification of key trends and developments.
Scott Power
Senior Analyst
Morgans
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Scott Power
Senior Analyst
Morgans
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
Jun Bei Liu: The AI winners of the ASX
Livewire Markets
Equities
How to find an ASX "super stock" early (and an example of one)
HD Capital Partners